Strata Skin Sciences PE Ratio 2010-2023 | SSKN
Current and historical p/e ratio for Strata Skin Sciences (SSKN) from 2010 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Strata Skin Sciences PE ratio as of April 25, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Strata Skin Sciences PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2024-04-26 | 0.51 | 0.00 | |
| 2023-12-31 | 0.55 | $-0.31 | 0.00 |
| 2023-09-30 | 0.60 | $-0.20 | 0.00 |
| 2023-06-30 | 0.95 | $-0.20 | 0.00 |
| 2023-03-31 | 1.06 | $-0.16 | 0.00 |
| 2022-12-31 | 0.79 | $-0.15 | 0.00 |
| 2022-09-30 | 0.87 | $-0.17 | 0.00 |
| 2022-06-30 | 0.96 | $-0.16 | 0.00 |
| 2022-03-31 | 1.47 | $-0.08 | 0.00 |
| 2021-12-31 | 1.47 | $-0.08 | 0.00 |
| 2021-09-30 | 1.84 | $-0.07 | 0.00 |
| 2021-06-30 | 1.56 | $-0.09 | 0.00 |
| 2021-03-31 | 1.67 | $-0.17 | 0.00 |
| 2020-12-31 | 1.50 | $-0.13 | 0.00 |
| 2020-09-30 | 1.35 | $-0.14 | 0.00 |
| 2020-06-30 | 1.15 | $-0.13 | 0.00 |
| 2020-03-31 | 0.95 | $-0.08 | 0.00 |
| 2019-12-31 | 2.08 | $-0.05 | 0.00 |
| 2019-09-30 | 2.15 | $-0.03 | 0.00 |
| 2019-06-30 | 2.49 | $-0.01 | 0.00 |
| 2019-03-31 | 2.85 | $-0.07 | 0.00 |
| 2018-12-31 | 2.60 | $-0.20 | 0.00 |
| 2018-09-30 | 3.54 | $-0.30 | 0.00 |
| 2018-06-30 | 2.05 | $-5.81 | 0.00 |
| 2018-03-31 | 1.17 | $-6.27 | 0.00 |
| 2017-12-31 | 1.23 | $-7.17 | 0.00 |
| 2017-09-30 | 1.77 | $-7.52 | 0.00 |
| 2017-06-30 | 2.43 | $-2.70 | 0.00 |
| 2017-03-31 | 3.03 | $-3.33 | 0.00 |
| 2016-12-31 | 2.20 | $-3.60 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.019B | $0.033B |
| Strata Skin Sciences, Inc. is a medical technology company which focused on the dermatology market. Its products include the XTRAC laser(R) and VTRAC(R) excimer lamp systems for treatment of psoriasis, vitiligo and other skin conditions as well as the MelaFind (R) system used for identification and management of melanoma skin cancer. Strata Skin Sciences, Inc., formerly known as MELA Sciences, Inc., is based in Horsham, Pennsylvania. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $39.221B | 21.82 |
| Inspire Medical Systems (INSP) | United States | $6.999B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.463B | 0.00 |
| Axonics (AXNX) | United States | $3.394B | 0.00 |
| 10x Genomics (TXG) | United States | $3.206B | 0.00 |
| Enovis (ENOV) | United States | $3.022B | 22.96 |
| Azenta (AZTA) | United States | $2.872B | 234.09 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.869B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $2.629B | 0.00 |
| Privia Health (PRVA) | United States | $2.135B | 94.68 |
| Schrodinger (SDGR) | United States | $1.688B | 0.00 |
| Omnicell (OMCL) | United States | $1.246B | 30.48 |
| Phreesia (PHR) | United States | $1.154B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.793B | 0.00 |
| Standard BioTools (LAB) | United States | $0.685B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.599B | 0.00 |
| Talkspace (TALK) | United States | $0.520B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.332B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.328B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.323B | 0.00 |
| Pulmonx (LUNG) | United States | $0.281B | 0.00 |
| American Well (AMWL) | United States | $0.156B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.152B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.147B | 0.00 |
| Augmedix (AUGX) | United States | $0.136B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.131B | 0.00 |
| Outset Medical (OM) | United States | $0.123B | 0.00 |
| TruBridge (TBRG) | United States | $0.115B | 4.91 |
| 111 (YI) | China | $0.084B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.077B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.070B | 0.00 |
| HeartBeam (BEAT) | United States | $0.052B | 0.00 |
| Zepp Health (ZEPP) | China | $0.052B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.045B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.031B | 0.00 |
| Movano (MOVE) | United States | $0.027B | 0.00 |
| Cue Health (HLTH) | United States | $0.023B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.022B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.020B | 0.00 |
| Akili (AKLI) | United States | $0.019B | 0.00 |
| CareCloud (CCLD) | United States | $0.017B | 0.00 |
| ETAO (ETAO) | United States | $0.015B | 0.00 |
| Centogene (CNTG) | Germany | $0.013B | 0.00 |
| Biotricity (BTCY) | United States | $0.012B | 0.00 |
| Transgenomic (PRPO) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| Syra Health (SYRA) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |